When the American Cancer Society talks about improved 5-year cancer survival rates, it sounds like good news. And it is. As ...
To evaluate the clinical benefit of extended endocrine therapy after 5 years of adjuvant treatment with LHRHa in premenopausal women with node-positive, HR-positive early breast cancer.
Netherlands data reveal how lentigo maligna is treated in the Netherlands, with notable upstaging and recurrence rates. Read ...
Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...
References: 1. Thailand Food and Drug Administration. Public Pharmaceutical Regulatory Information: NERLYNX. Available at: ...
The Chosun Ilbo on MSN
Coffee consumption linked to improved survival in colorectal cancer patients
A study has found that coffee consumption may help improve survival rates and reduce recurrence risks in colorectal cancer ...
Circular tumor DNA (ctDNA) positivity is associated with poorer survival and higher recurrence rates among patients with non–small cell lung cancer (NSCLC), but early detection may allow for timely ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix®, Kit for the preparation ...
Dr. Mariano Barbacid, a pioneering Spanish cancer scientist, alongside his team have eliminated aggressive pancreatic tumours ...
Two Lancaster firms working to develop cures for specific types of cancer are expanding overseas. A&A Biotech and R&M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results